Missed Opportunities for Advance Care Planning After GI Surgery Multiple admissions typical leading up to urgent procedures followed by discharge to hospice Jul 07, 2022
CEND-1 Offers Hope in Advanced Pancreatic Cancer Phase I study showed good safety profile, no dose-limiting toxicities, and encouraging activity Jul 06, 2022
Fewer Complications With Robotic Nephrectomy in Complex Kidney Tumors However, trial comparing robotic and open surgery was stopped early due to low enrollment Jul 06, 2022
FDA Warns of Increased Mortality Risk With Duvelisib Drug approved for adults with CLL/SLL Jul 01, 2022
Hep C Cure Aside, Some Patients Still Benefit From Liver Cancer Screening Hepatocellular carcinoma risk persisted after direct-acting antivirals Jun 30, 2022
Therapeutic Use of Cannabis: Risks, Benefits, Legality Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
Art, Drama, and a Terminal Illness How Ellen Dunphy turned her cancer diagnosis into art Jun 28, 2022 podcast
Over $20 Million Paid to a Select Group of Top U.S. Oncologists "The findings identify a risk for perceived and real conflict of interest," study author says Jun 27, 2022
Kidney Failure May Drive COVID Deaths in People With Sickle Cell Trait COVID-19 severity strongly linked with sickle cell anemia as well Jun 27, 2022
Toby Keith's Gastric Cancer The country star announced he's been treated for the last 6 months Jun 23, 2022
Adding Opdivo in First-Line Shows Promise in HER2+ Esophagogastric Cancer Improved OS compared with historical standard or chemo-free approach Jun 23, 2022
Do Therapy-Related Hot Flashes in Breast Cancer Signal Worse Outcomes? Swedish study finds reduced DFS in women who used drugs for hot flashes Jun 22, 2022
Brentuximab Vedotin Boosts Survival in Untreated Hodgkin Lymphoma ECHELON-1 analysis showed 41% mortality risk reduction versus standard treatment Jun 21, 2022
Drugmaker Pulls Third-Line PARP Inhibitor Approval in Ovarian Cancer Decision on rucaparib follows negative OS signal and "discussions" with FDA Jun 17, 2022
MRI-Guided HIFU Effective in Intermediate-Risk Prostate Cancer QOL outcomes compared favorably with radical prostatectomy and radiotherapy, researchers said Jun 17, 2022
Xtandi During AS Reduced Progression Risk in Early Prostate Cancer Risk of disease progression cut by 46% versus those on active surveillance alone Jun 16, 2022
Early Anal Lesion Treatment Cuts Cancer Risk in People With HIV ANCHOR data support screening and treatment for anal HSIL in those ages 35 and up Jun 15, 2022
Harms of Cancer Blood Tests? FTC Healthcare Crackdown: More Smoke Than Fire? This past week in healthcare investigations Jun 15, 2022
Lorlatinib Reduces CNS Progression in ALK-Positive NSCLC Post-hoc analysis of CROWN trial does find more central nervous system toxicity, however Jun 14, 2022
Does Ditching Cost-Sharing Boost Follow-Up Colonoscopy? States saw differing results with policies eliminating costs after a positive noninvasive test Jun 14, 2022
Studies Reinforce Prognostic Role for Circulating Tumor Cells in Myeloma At higher levels, different cutoffs show at least a doubling of PFS, OS hazard ratios Jun 13, 2022
Diabetes Threatens Long-Term Survival in Metastatic Breast Cancer 5-year survival rates were not affected, however Jun 13, 2022
FDA Panel Backs Gene Tx for Degenerative Brain Disorder in Kids Advisers unanimously recommend approval for pediatric ALD patients without HLA-matched donors Jun 10, 2022
Something Fishy About Tuna and Melanoma Risk Higher total fish intake linked with 22% higher risk of malignant tumors Jun 09, 2022
P53 Antagonist Shows Early Activity in Advanced Liposarcoma ASCO roundup: ADC targeting CD46 slows mCRPC, molecule stabilizes effects of "hot spot" mutation Jun 08, 2022
Intensified Regimen for Metastatic CRC Fails to Improve Outcomes Combination of modified FOLFOXIRI/panitumumab also caused greater toxicity, study showed Jun 08, 2022
A Better Way to Irradiate Lethal CNS Metastases? Randomized trial makes case for proton craniospinal irradiation for leptomeningeal spread Jun 08, 2022
First-Line Anti-EGFR Extends OS in Left-Sided Colorectal Cancer "A win for a highly selected group of patients," says ASCO expert Jun 07, 2022
PARP Inhibitor Picks Up a Win in Frontline Maintenance for Ovarian Cancer Median PFS more than doubled with rucaparib after response to platinum-based chemotherapy Jun 07, 2022
Forego Radiotherapy for Women With Low-Risk Luminal A Breast Cancer? Study shows 5-year local recurrence rate of 2.3% with lumpectomy and endocrine therapy alone Jun 07, 2022
She Found Out She Had Prostate Cancer Then Eve Gammill, a transgender woman, fully embraced her feminine identity Jun 07, 2022
Targeted Combo Topples Chemo in Pediatric Glioma With BRAF Mutations ORR quadrupled, median PFS nearly tripled with dabrafenib plus trametinib in low-grade disease Jun 06, 2022
Radiation Alone May Suffice for Some Nasopharyngeal Cancer Chemotherapy adds little benefit in intermediate grade lesions Jun 06, 2022
Novel Agent Lessens Mucositis in Head and Neck Cancers IV infusion could allow more patients to complete treatment regimen Jun 06, 2022
Tiragolumab Fails in Extensive-Stage Small Cell Lung Cancer No change in survival when combined with atezolizumab and chemotherapy Jun 06, 2022
Liquid Biopsy May Save Colon Cancer Patients From Chemo Circulating tumor DNA could determine who needs more therapy Jun 06, 2022
Endocrine Switch Plus Ribociclib Active in Post-CDK4/6 Inhibitor Progression First randomized support for strategy in progressive metastatic HR+/HER2- breast cancer Jun 06, 2022
Myeloma Trial Supports 'Personalized Approach' to Upfront Transplant DETERMINATION confirms benefit in triple-therapy setting, but suggests timing can be tailored Jun 06, 2022
Complete Responses in 100% of dMMR Rectal Cancer With Neoadjuvant PD-1 Inhibition Chemo, RT, surgery avoided in short-term follow-up but study population was small Jun 05, 2022
Trastuzumab Deruxtecan Ushers in New Treatment Era for HER2-Low Breast Cancer DESTINY-Breast04 extends agent's benefits to historically tough-to-treat disease Jun 05, 2022
